FibroGen, Inc (FGEN) Social Stream



FibroGen, Inc (FGEN): $11.62

-0.09 (-0.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Fibrogen Inc (FGEN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Fibrogen Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $30 $14 $24.333 $12.02 102.44%
2021-12-22 9 $29 $14 $21.166 $12.02 76.09%
2022-01-06 9 $29 $14 $21 $12.02 74.71%
2022-01-13 8 $29 $14 $19.6 $12.02 63.06%
2022-03-01 7 $29 $14 $19.6 $12.02 63.06%
2022-03-02 7 $29 $13 $19.2 $12.02 59.73%

The Trend in the Analyst Price Target


FGEN's average price target has moved down $21.37 over the prior 44 weeks.

Over the past 44 weeks, FGEN's average upside potential has been 60.87%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 10 56 25 40.57 21.14 91.91%
2021-07-24 10 35 16 24.71 13.27 86.21%
2022-01-06 9 29 14 20.40 13.93 46.45%
2022-01-13 7 29 14 19.60 14.00 40%
2022-03-01 7 29 14 19.60 13.62 43.91%

FGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 7 0 0 7

The Trend in the Broker Recommendations


FGEN's average broker recommendation rating worsened by 1.11 over the prior 23 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Fibrogen Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -486.31% of that group.
  • In terms of how Fibrogen Inc fares relative to all US stocks, note that its average analyst price target is higher than 166.22% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Fibrogen Inc's upside potential (average analyst target price relative to current price) is higher than 188.48% of them.
  • In the context of Pharmaceutical Products stocks, Fibrogen Inc's number of analysts covering the stock is higher than 487.27% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Fibrogen Inc are EVO, ESPR, and ERAS.

What is the outlook for FGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7767 seconds.